Boston Medical Sciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $35.1M

  • Investors
  • 12

Boston Medical Sciences General Information

Description

Developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. The company's platform utilizes artificial intelligence to perform virtual bowel cleansing, which helps prepare the colon for examination without the traditional discomfort associated with laxatives, enabling healthcare providers with enhanced detection and treatment through technology.

Contact Information

Website
www.b-ms.tech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • R.core Nihonbashi Ningyocho Building 6 Floor
  • 7-13, Nihonbashi-tomizawacho, Chuo-ku
  • Tokyo, 103-0006
  • Japan
Primary Industry
Decision/Risk Analysis
Other Industries
Enterprise Systems (Healthcare)
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Oncology
Corporate Office
  • R.core Nihonbashi Ningyocho Building 6 Floor
  • 7-13, Nihonbashi-tomizawacho, Chuo-ku
  • Tokyo, 103-0006
  • Japan

Boston Medical Sciences Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boston Medical Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 13-Nov-2026 $35.1M Completed Generating Revenue
2. Early Stage VC (Series A) 08-Oct-2024 Completed Generating Revenue
1. Seed Round 05-Oct-2023 $2.7M $2.7M Completed Generating Revenue
To view Boston Medical Sciences’s complete valuation and funding history, request access »

Boston Medical Sciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class A-2 Preferred Shares
Class A Preferred Shares
S Preferred Shares 25,000 $55.63 $55.63 1x $55.63 15.82%
To view Boston Medical Sciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Boston Medical Sciences Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Boston Medical Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4767946-A1 Acquisition method for virtually cleaned intestinal tract image Pending 22-Aug-2023
WO-2025041364-A1 Acquisition method for virtually cleaned intestinal tract image Inactive 22-Aug-2023

Boston Medical Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boston Medical Sciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daiwa House Ventures Corporate Venture Capital Minority
Japan Growth Capital Investment Corporation Venture Capital Minority
Nomura SPARX Investment Growth/Expansion Minority
CHCP PE-Backed Company Minority
Eukaria Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Boston Medical Sciences FAQs

  • When was Boston Medical Sciences founded?

    Boston Medical Sciences was founded in 2023.

  • Where is Boston Medical Sciences headquartered?

    Boston Medical Sciences is headquartered in Tokyo, Japan.

  • What is the size of Boston Medical Sciences?

    Boston Medical Sciences has 47 total employees.

  • What industry is Boston Medical Sciences in?

    Boston Medical Sciences’s primary industry is Decision/Risk Analysis.

  • Is Boston Medical Sciences a private or public company?

    Boston Medical Sciences is a Private company.

  • What is Boston Medical Sciences’s current revenue?

    The current revenue for Boston Medical Sciences is .

  • How much funding has Boston Medical Sciences raised over time?

    Boston Medical Sciences has raised $44.3M.

  • Who are Boston Medical Sciences’s investors?

    Daiwa House Ventures, Japan Growth Capital Investment Corporation, Nomura SPARX Investment, CHCP, and Eukaria are 5 of 12 investors who have invested in Boston Medical Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process